Related Experiment Video
Updated: Jun 3, 2026
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Cost of AF Ablation: Where Do We Stand?
1Heart Rhythm Program, Southlake Regional Health Centre, Newmarket, ON, Canada L3Y 8C3.
Insights
Atrial fibrillation (AF) treatment costs are substantial. Catheter ablation offers a promising alternative for symptomatic AF patients, with this paper examining its financial implications.
Area of Science:
- Cardiology
- Health Economics
Background:
- Atrial fibrillation (AF) is a prevalent, disabling chronic condition impacting an aging population.
- AF incurs significant direct medical costs and indirect costs due to complications and reduced quality of life.
Purpose of the Study:
- To review the financial implications of catheter ablation for atrial fibrillation.
- To present evidence on the cost-effectiveness of AF ablation.
Main Methods:
- Literature review of published data on AF ablation costs.
- Analysis of authors' experience with AF ablation financial data.
Main Results:
- Catheter ablation is an emerging alternative to traditional AF management.
- Evidence on the financial impact of AF ablation is presented.
Conclusions:
- Catheter ablation presents a significant therapeutic option for symptomatic AF.
- Understanding the financial implications of AF ablation is crucial for healthcare providers and patients.
Abstract:
Atrial fibrillation (AF) is a common and frequently disabling chronic condition associated with significant patient morbidity and affecting an increasing stratum of our ageing society. Direct costs related to atrial fibrillation are comprised from direct cost of medical therapy, catheter ablation, and related hospitalizations and imaging procedures, with indirect costs related to complications of the primary therapeutic strategy, management of related conditions, as well as disability and loss in quality of life related to AF. Over the last decade, catheter ablation became a promising alternative to rate and rhythm control among symptomatic AF patients. The purpose of this paper is to describe the evidence on the financial implications related to ablation based on published data and authors' experience.
